UBS on $45bn in dry powder

Secondaries buyers are casting a wider net to fish for credit, intellectual property, healthcare royalties, and other sorts of illiquid assets, says Rodney Reid, head of UBS' secondaries activity for EMENA.

SECONDARIES INVESTOR

Register to unlock this content

• Daily global secondaries market news and intelligence
• Curated insights to keep you ahead of GP-led and LP-led secondaries
• Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
• Access to proprietary research and reports
• Selected fund performance and investor activity data

Register nowFind out more

Q&AEuropeUSDirect Secondaries